Cablivi
Payments companies reported to CMS as associated with Cablivi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cablivi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cablivi
These are the largest totals companies reported as associated with Cablivi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gustaaf De Ridder | Danville, PA | Anatomic Pathology & Clinical Pathology | $91,364.12 |
| Jamile Shammo | Chicago, IL | Hematology & Oncology | $65,674.80 |
| Jeffrey Laurence | New York, NY | Hematology & Oncology | $63,358.41 |
| Vivek Sharma | Louisville, KY | Hematology & Oncology | $46,929.21 |
| Maissaa Janbain | New Orleans, LA | Hematology & Oncology | $44,552.64 |
| Hillary Maitland | Charlottesville, VA | Hematology (Internal Medicine) | $43,870.16 |
| Kanwarpal Kahlon | Burbank, CA | Hematology & Oncology | $37,500.40 |
| Jay Raval | Los Ranchos, NM | Blood Banking & Transfusion Medicine | $34,984.48 |
| Xinglong Zheng | Birmingham, AL | Blood Banking & Transfusion Medicine | $31,159.22 |
| Srikanth Nagalla | Miami, FL | Hematology & Oncology | $19,514.95 |
Prescribed Cablivi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.